Figure 2.
Gene expression (RPA) of TIMPs in relation to the control gene rpL32 in PBMCs from 15 patients with WG classified as having active disease (n = 7) or being in remission (n = 8) according to the BVAS, serum levels of CRP, and ESR (see table 1) and 15 healthy controls. Data are given as mean (SEM). *p<0.01 and **p<0.001 versus active disease and healthy controls.